SFIL Annual financial report 2018

5 I Shareholders’ Meeting of may 29, 2019 138 SFIL Annual Financial Report 2018 G. Amendment to the liquity agreement between CDC and SFIL Persons concerned: Mrs. Delphine de Chaisemartin, director of SFIL (until March 29, 2018) and representing the interest of the Caisse des dépôts et consignations, shareholder. Nature and purpose: This agreement, signed in May 28, 2014, focuses on a loan agreement between SFIL and CDC. It complies with the requests of ACPR, reduces the overall financing costs of SFIL and reduces the amount of the ceiling for the commitment of CDC and its exposure on SFIL. Terms and conditions: This amendment was authorized by the Board of Directors in May 23, 2014. The financial impacts of this agreement and its amendments in respect of fiscal year 2018 are described in B. 1. Amendment of July 16, 2015 Persons concerned: Mrs. Delphine de Chaisemartin, director of SFIL (until March 29, 2018) and representing the interest of the Caisse des dépôts et consignations, shareholder. Nature and purpose: This amendment was signed in July 16, 2015. It provides, as a result of the launch of the new credit export activity, the fol- lowing modifications to the loan agreement between SFIL and CDC: •  halt in funding related to the LBP activity; •  unsecured requirements financed by CDC with an amount premium (increase by 5bp for amounts exceeding EUR 750 million); •  SFIL undertakes to continue to reduce the over-collateralization rate up to 11.5% in 2018. Terms and conditions: The financial impacts of this agreement and its amendments in respect of fiscal year 2018 are described in B. Paris-la-Défense, April 1, 2019 The Statutory Auditors French original signed by DELOITTE & ASSOCIÉS ERNST & YOUNG et Autres Sylvie BOURGUIGNON Vincent ROTY